XML 44 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Debt
12 Months Ended
Dec. 31, 2021
Debt [Abstract]  
Debt [Text Block]
Note 20 – Debt
Debt as of December 31, 2021 and 2020 includes the following:
As of December 31, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.62%
$
211,955
1.65%
$
160,000
U.S. Term Loan
1.65%
540,000
1.65%
570,000
EURO Term Loan
1.50%
137,616
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
1,777
Various
2,072
Total debt
$
901,348
$
899,134
Less: debt issuance costs
(8,001)
(11,099)
Less: short-term and current portion of long-term debts
(56,935)
(38,967)
Total long-term debt
$
836,412
$
849,068
Credit facilities
The Company’s primary credit facility
 
(as amended, the “Credit Facility”) is comprised of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term
 
Loan” and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower, each
 
with a
five year
 
term maturing in
August 2024
.
 
Subject to the consent of the administrative agent and certain other conditions, the Company
 
may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be increased by up
 
to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based upon the Company’s
consolidated net leverage ratio.
 
On December 10, 2021, the Company entered into the Second Amendment with Bank of America
N.A., to include among other things, an update to provide for use of a non-USD
 
currency LIBOR successor rate.
 
The variable interest
rate incurred on the outstanding borrowings under the Credit Facility as of and
 
during the year ended December 31, 2021 was
approximately
1.6
%.
 
In addition to paying interest on outstanding principal under the Credit Facility,
 
the Company is required to pay
a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s consolidated
 
net leverage ratio to the lenders under the
Revolver in respect of the unutilized commitments thereunder.
 
The Company has unused capacity under the Revolver of
approximately $
184
 
million, net of bank letters of credit of approximately $
4
 
million, as of December 31, 2021.
The Credit Facility is subject to certain financial and other covenants
 
.
 
The Company’s initial consolidated net
 
debt to
consolidated adjusted EBITDA ratio could not exceed
4.25
 
to 1, with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of December 31, 2021, the consolidated net debt to adjusted EBITDA
 
may not exceed
3.75
 
to 1.
 
The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than
3.0
 
to 1 over the term of the agreement.
 
The Credit
Facility also prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividend paid annually
exceeds the greater of $
50.0
 
million and
20
% of consolidated adjusted EBITDA unless the ratio of consolidated net debt
 
to
consolidated adjusted EBITDA is less than
2.0
 
to 1, in which case there is no such limitation on amount.
 
As of December 31, 2021
and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have quarterly
principal amortization during their five year terms, with
5.0
% amortization of the principal balance due in years 1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at maturity.
 
During the year ended December 31, 2021, the
Company made four quarterly amortization payments related to the
 
Term Loans totaling $
38.0
 
million.
 
The Credit Facility is
guaranteed by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially all of the assets of
the Company and the domestic subsidiary guarantors, subject to certain
 
customary exclusions.
 
The obligations of the Dutch borrower
are guaranteed only by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base rate of
1.64
%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of December 31, 2021,
 
the aggregate interest rate on the swaps, including the fixed base rate
plus an applicable margin, was
3.1
%.
 
See Note 25 of Notes to Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection with executing
 
the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Consolidated
 
Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were attributed to the
Revolver and recorded within other assets on the Company’s
 
Consolidated Balance Sheet.
 
These capitalized costs are being
amortized into interest expense over the
five year
 
term of the Credit Facility.
 
As of December 31, 2021 and 2020, the Company had
$
8.0
 
million and $
11.1
 
million, respectively, of debt
 
issuance costs recorded as a reduction of long-term debt.
 
As of December 31,
2021 and 2020, the Company had $
4.3
 
million and $
5.9
 
million, respectively, of
 
debt issuance costs recorded within other non-current
assets.
Industrial development bonds
As of December 31, 2021 and 2020, the Company had fixed rate, industrial
 
development authority bonds totaling $
10.0
 
million in
principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
 
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting
 
facilities in certain foreign subsidiaries, which are not
collateralized.
 
The Company’s other debt obligations
 
primarily consist of certain domestic and foreign low interest rate or interest-
free municipality-related loans, local credit facilities of certain foreign subsidiaries
 
and capital lease obligations.
 
Total unused
capacity under these arrangements as of December 31, 2021, was approximately
 
$
26
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection
 
above, the Company’s only other
 
off-balance
sheet arrangements include certain financial and other guarantees.
 
The Company’s total bank letters
 
of credit and guarantees
outstanding as of December 31, 2021 were approximately $
6
 
million.
The Company incurred the following debt related expenses included
 
within Interest expense, net, in the Consolidated Statements
of Income:
Year
 
Ended December 31,
2021
2020
2019
Interest expense
$
19,089
$
23,552
$
16,788
Amortization of debt issuance costs
4,749
4,749
1,979
Total
$
23,838
$
28,301
$
18,767
Based on the variable interest rates associated with the Credit Facility,
 
as of December 31, 2021 and 2020, the amounts at which
the Company’s total debt were recorded
 
are not materially different from their fair market value.
At December 31, 2021, annual maturities on long-term borrowings maturing
 
in the next five fiscal years (excluding the reduction
to long-term debt attributed to capitalized and unamortized debt issuance costs)
 
are as follows:
2022
$
56,978
2023
75,765
2024
758,241
2025
298
2026
145